Birchview Capital, LP Bristol Myers Squibb CO Transaction History

Birchview Capital, LP

$108 Million
Q3 2024

A detailed history of Birchview Capital, LP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Birchview Capital, LP holds 686,182 shares of BMY stock, worth $40.4 Million. This represents 32.76% of its overall portfolio holdings.

Number of Shares

686,182

Previous 688,218 0.3%

Holding current value

$40.4 Million

Previous $28.6 Million 24.24%

% of portfolio

32.76%

Previous 28.56%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$39.66 - $51.75 $80,747 - $105,363	-2,036 Reduced 0.3%	686,182 $35.5 Million
Q2 2024 Aug 13, 2024	SELL	$40.25 - $52.99 $619,367 - $815,410	-15,388 Reduced 2.19%	688,218 $28.6 Million
Q1 2024 May 14, 2024	SELL	$47.98 - $54.4 $608,914 - $690,390	-12,691 Reduced 1.77%	703,606 $38.2 Million
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $711,352 - $795,402	-12,288 Reduced 1.69%	716,297 $41.6 Million
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $52,567 - $59,624	800 Added 0.11%	728,585 $50.5 Million
Q2 2022 Aug 12, 2022	SELL	$72.62 - $79.98 $1.91 Million - $2.11 Million	-26,321 Reduced 3.49%	727,785 $56 Million
Q1 2022 May 13, 2022	SELL	$61.48 - $73.72 $737,760 - $884,640	-12,000 Reduced 1.57%	754,106 $55.1 Million
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $1.61 Million - $1.88 Million	-30,000 Reduced 3.77%	766,106 $47.8 Million
Q2 2021 Aug 10, 2021	BUY	$61.91 - $67.42 $118,867 - $129,446	1,920 Added 0.24%	796,106 $53.2 Million
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $11,868 - $13,347	-200 Reduced 0.03%	794,186 $50.1 Million
Q3 2020 Nov 12, 2020	BUY	$57.43 - $63.64 $114,860 - $127,280	2,000 Added 0.25%	794,386 $47.9 Million
Q2 2020 Aug 10, 2020	BUY	$54.82 - $64.09 $361,866 - $423,058	6,601 Added 0.84%	792,386 $46.6 Million
Q1 2020 May 12, 2020	BUY	$46.4 - $67.43 $334,080 - $485,496	7,200 Added 0.92%	785,785 $43.8 Million
Q4 2019 Feb 12, 2020	BUY	$49.21 - $64.19 $36 Million - $47 Million	731,585 Added 1556.56%	778,585 $50 Million
Q3 2019 Nov 12, 2019	BUY	$42.77 - $50.71 $128,310 - $152,130	3,000 Added 6.82%	47,000 $2.38 Million
Q2 2019 Aug 06, 2019	BUY	$44.62 - $49.34 $1.07 Million - $1.18 Million	24,000 Added 120.0%	44,000 $2 Million
Q1 2019 May 03, 2019	BUY	$45.12 - $53.8 $902,400 - $1.08 Million	20,000 New	20,000 $954,000

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Birchview Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Birchview Capital, LP with notifications on news.

Account

Birchview Capital, LP Bristol Myers Squibb CO Transaction History